BioStem files registration statement with SEC, to pursue Nasdaq listing
BioStem Technologies announced the filing of a Form 10 registration statement with the SEC to register its shares of common stock pursuant to the Securities Exchange Act of 1934, as amended, and reaffirmed its strategic decision to pursue a listing on Nasdaq. "The filing of our Registration Statement is an important mi